Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
16 hedge funds and large institutions have $1.09M invested in Sophiris Bio, Inc. in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
14% more funds holding
Funds holding: 14 → 16 (+2)
9% more capital invested
Capital invested by funds: $998K → $1.09M (+$89K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Gruss Capital Management
New York
|
+$26.2K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
+$17.3K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$524 |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$513 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$174 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$33K |
| 2 |
Citigroup
New York
|
-$2.22K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.19K |
SPHS Hedge Fund Activity: Q1 2015 in Review
16 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q1 2015, worth a combined $1.09M — up 8.9% from $998K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new SPHS positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Gruss Capital Management, adding an estimated $26.2K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $33K sold.
- 16 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q1 2015, up from 14 in Q4 2014.
- Funds reported $1.09M of Sophiris Bio, Inc. stock for Q1 2015, up 8.9% quarter-over-quarter.
- 3 funds opened new Sophiris Bio, Inc. positions in Q1 2015 and 1 closed out, a net change of +2 holders.
- The largest Sophiris Bio, Inc. buyer in Q1 2015 was Gruss Capital Management, an estimated $26.2K added.
- The largest Sophiris Bio, Inc. seller in Q1 2015 was Virtu KCG Holdings, an estimated $33K sold.
Based on aggregated 13F filings for Q1 2015.